Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

New anti-HCV agents described by researchers at K.U. Leuven and Gilead

Feb. 23, 2004

Small-molecule CFTR inhibitor for prevention of toxin-induced secretory diarrhea

Feb. 23, 2004

PEG-Intron Redipen gets U.S. launch

Feb. 19, 2004

Axxima discovers casein kinase CKI inhibitors with utility in HCV infection

Feb. 18, 2004

Toll-like receptor 9 mediates beneficial effects of probiotics in vivo

Feb. 18, 2004

Merck & Isis collaboration yields novel HCV NS5B inhibitors

Feb. 16, 2004

Significant improvements reported with atorvastatin in NASH

Feb. 16, 2004

Nabi signs distribution agreement with Kamada for Nabi-HB

Feb. 12, 2004

Probactrix IBS trial commences enrollment

Feb. 10, 2004

Micrologix Biotech acquires celgosivir rights

Feb. 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...